India is at a critical juncture in its medical technology sector, transitioning from dependence on imports to developing a manufacturing and innovation ecosystem. To establish itself as a global hub for medical devices, the country needs significant regulatory reforms, moving beyond inadequate historical frameworks like the Drugs and Cosmetics Act of 1940.
Current regulatory complexities inhibit growth, with a lack of clear alignment between medical devices and their regulatory oversight. India must harmonize its regulations with international standards while ensuring robust infrastructure capable of supporting the medical technology value chain, including critical components and manufacturing.
Successful clusters, such as the Andhra Pradesh Medical Technology Zone, emphasize the importance of shared resources and collaboration among firms to deliver comprehensive healthcare solutions.
To achieve its goal of import neutrality by 2032, India must implement stronger, coherent regulations that enhance safety, reduce investment risks, and attract global partnerships. If successful, India could emerge as a leader in affordable, high-quality medical technology for global markets.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.millenniumpost.in/opinion/indias-medtech-bottleneck-656007
